Efficacy of alfuzosin after shock wave lithotripsy for the treatment of ureteral calculi

Korean Journal of Urology

Volumn 54, Issue 2, 2013, Pages 106-110

  Cho, Hee Ju ^a   Shin, Soon Cheol ^a   Seo, Do Young ^a   Min, Dong Suk ^a   Cho, Jeong Man ^a   Kang, Jung Yoon ^a   Yoo, Tag Keun ^a  

^a Eulji University School of Medicine   (South Korea)

Author keywords

Alfuzosin; Lithortripsy; Urolithiasis

Indexed keywords

ALFUZOSIN; LOXOPROFEN;

ADULT; ARTICLE; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; EXTRACORPOREAL LITHOTRIPSY; FEMALE; FOLLOW UP; HUMAN; ILIAC CREST; KIDNEY COLIC; MALE; PAIN ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETROGRADE EJACULATION; SINGLE BLIND PROCEDURE; URETER STONE; URETEROPELVIC JUNCTION; VISUAL ANALOG SCALE;

EID: 84874335922     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2013.54.2.106     Document Type: Article

References (30)

1. Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, et al. Ureteral Stones Clinical Guidelines Panel summary report on the management of ureteral calculi. The American Urological Association. J Urol 1997;158:1915-21.
2. Eisner BH, Reese A, Sheth S, Stoller ML. Ureteral stone location at emergency room presentation with colic. J Urol 2009;182: 165-8.
3. Kijvikai K, Haleblian GE, Preminger GM, de la Rosette J. Shock wave lithotripsy or ureteroscopy for the management of proximal ureteral calculi: an old discussion revisited. J Urol 2007;178(4 Pt 1):1157-63.
4. Sayed MA, el-Taher AM, Aboul-Ella HA, Shaker SE. Steinstrasse after extracorporeal shockwave lithotripsy: aetiology, prevention and management. BJU Int 2001;88:675-8.
5. Resim S, Ekerbicer HC, Ciftci A. Role of tamsulosin in treatment of patients with steinstrasse developing after extracorporeal shock wave lithotripsy. Urology 2005;66:945-8.
6. Kobayashi S, Tomiyama Y, Maruyama K, Hoyano Y, Yamazaki Y, Kusama H. Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters. J Smooth Muscle Res 2009;45:187-95.
7. Park HK, Choi EY, Jeong BC, Kim HH, Kim BK. Localizations and expressions of alpha-1A, alpha-1B and alpha-1D adrenoceptors in human ureter. Urol Res 2007;35:325-9.
8. Hollingsworth JM, Rogers MA, Kaufman SR, Bradford TJ, Saint S, Wei JT, et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 2006;368:1171-9.
9. Parsons JK, Hergan LA, Sakamoto K, Lakin C. Efficacy of alphablockers for the treatment of ureteral stones. J Urol 2007;177: 983-7.
10. Singh A, Alter HJ, Littlepage A. A systematic review of medical therapy to facilitate passage of ureteral calculi. Ann Emerg Med 2007;50:552-63.
11. Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S, Kohri K. Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol 2007;14:749-53.
12. Kupeli B, Irkilata L, Gurocak S, Tunc L, Kirac M, Karaoglan U, et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy? Urology 2004;64:1111-5.
13. Kobayashi M, Naya Y, Kino M, Awa Y, Nagata M, Suzuki H, et al. Low dose tamsulosin for stone expulsion after extracorporeal shock wave lithotripsy: efficacy in Japanese male patients with ureteral stone. Int J Urol 2008;15:495-8.
14. Falahatkar S, Khosropanah I, Vajary AD, Bateni ZH, Khosropanah D, Allahkhah A. Is there a role for tamsulosin after shock wave lithotripsy in the treatment of renal and ureteral calculi? J Endourol 2011;25:495-8.
15. Wang H, Liu K, Ji Z, Li H. Effect of alpha1-adrenergic antagonists on lower ureteral stones with extracorporeal shock wave lithotripsy. Asian J Surg 2010;33:37-41.
16. Gravas S, Tzortzis V, Karatzas A, Oeconomou A, Melekos MD. The use of tamsulozin as adjunctive treatment after ESWL in patients with distal ureteral stone: do we really need it? Results from a randomised study. Urol Res 2007;35:231-5.
17. Pedro RN, Hinck B, Hendlin K, Feia K, Canales BK, Monga M. Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study. J Urol 2008;179:2244-7.
18. Chau LH, Tai DC, Fung BT, Li JC, Fan CW, Li MK. Medical expulsive therapy using alfuzosin for patient presenting with ureteral stone less than 10 mm: a prospective randomized controlled trial. Int J Urol 2011;18:510-4.
19. Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H. The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol 2005;173:2010-2.
20. Ahmed AF, Al-Sayed AY. Tamsulosin versus alfuzosin in the treatment of patients with distal ureteral stones: prospective, randomized, comparative study. Korean J Urol 2010;51:193-7.
21. Cha WH, Choi JD, Kim KH, Seo YJ, Lee K. Comparison and efficacy of low-dose and standard-dose tamsulosin and alfuzosin in medical expulsive therapy for lower ureteral calculi: prospective, randomized, comparative study. Korean J Urol 2012;53:349-54.
22. Itoh Y, Okada A, Yasui T, Hamamoto S, Hirose M, Kojima Y, et al. Efficacy of selective e1A adrenoceptor antagonist silodosin in the medical expulsive therapy for ureteral stones. Int J Urol 2011; 18:672-4.
23. Richardson CD, Donatucci CF, Page SO, Wilson KH, Schwinn DA. Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned alpha 1-adrenergic receptor subtypes. Prostate 1997;33:55-9.
24. Grasso M, Fortuna F, Lania C, Blanco S. Ejaculatory disorders and alpha1-adrenoceptor antagonists therapy: clinical and experimental researches. J Transl Med 2006;4:31.
25. Roehrborn CG, Van Kerrebroeck P, Nordling J. Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies. BJU Int 2003;92:257-61.
26. Hofner K, Jonas U. Alfuzosin: a clinically uroselective alpha1-blocker. World J Urol 2002;19:405-12.
27. Lepor H. Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group. Urology 1998;51:892-900.
28. Narayan P, Bruskewitz R. A comparison of two phase III multicenter, placebo-controlled studies of tamsulosin in BPH. Adv Ther 2000;17:287-300.
29. Moriyama N, Nasu K, Takeuchi T, Akiyama K, Murata S, Nishimatsu H, et al. Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human vas deferens: comparison with those of epididymal and pelvic portions. Br J Pharmacol 1997;122:1009-14.
30. Giuliano F, Allard F, McKenna K, Jardin A, Benoit G, Bernabe J. Tamsulosin has more deleterious effects than alfuzosin on parameters characterizing ejaculation in anaesthetized rats [abstract]. Int J Impot Res 2002;14(suppl 3):S12.